Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of diseases, according to research published today in Nature Medicine.
Preventative medicine programmes such as the UK National Health Service’s Health Check and Healthier You programmes are aimed at improving our health and reducing our risk of developing diseases. While such strategies are inexpensive, cost effective and scalable, they could be made more effective using personalised information about an individual’s health and disease risk.
The rise and application of ‘big data’ in healthcare, assessing and analysing detailed, large-scale datasets makes it increasingly feasible to make predictions about health and disease outcomes and enable stratified approaches to prevention and clinical management.
Now, an international team of researchers from the UK and USA, working with biotech company SomaLogic, has shown that large-scale measurement of proteins in a single blood test can provide important information about our health and can help to predict a range of different diseases and risk factors.
Our bodies contain around 30,000 different proteins, which are coded for by our DNA and regulate biological processes. Some of these proteins enter the blood stream by purposeful secretion to orchestrate biological processes in health or in disease, for example hormones, cytokines and growth factors. Others enter the blood through leakage from cell damage and cell death. Both secreted and leaked proteins can inform health status and disease risk.
In a proof-of-concept study based on five observational cohorts in almost 17,000 participants, researchers scanned 5,000 proteins in a plasma sample taken from each participant. Plasma is the single largest component of blood and is the clear liquid that remains after the removal of red and white blood cells and platelets. The study resulted in around 85 million protein targets being measured.
The technique involves using fragments of DNA known as aptamers that bind to the target protein. In general, only specific fragments will bind to particular proteins – in the same way that only a specific key will fit in a particular lock. Using existing genetic sequencing technology, the researchers can then search for the aptamers and determine which proteins are present and in what concentrations.
The researchers analysed the results using statistical methods and machine learning techniques to develop predictive models – for example, that an individual whose blood contains a certain pattern of proteins is at increased risk of developing diabetes. The models covered a number of health states, including levels of liver fat, kidney function and visceral fat, alcohol consumption, physical activity and smoking behaviour, and for risk of developing type 2 diabetes and cardiovascular disease.
The accuracy of the models varied, with some showing high predictive powers, such as for percentage body fat, while others had only modest prognostic power, such as for cardiovascular risk. The researchers report that their protein-based models were all either better predictors than models based on traditional risk factors or would constitute more convenient and less expensive alternatives to traditional testing.
Many of the proteins are linked to a number of health states or conditions; for example, leptin, which modulates appetite and metabolism, was informative for predictive models of percentage body fat, visceral fat, physical activity and fitness.
One difference between genome sequencing and so-called ‘proteomics’ – studying an individual’s proteins in depth – is that whereas the genome is fixed, the proteome changes over time. It might change as an individual becomes more obese, less physically active or smokes, for example, so proteins will be able to track changes in an individual’s health status over a lifetime.
Proteins circulating in our blood are a manifestation of our genetic make-up as well as many other factors, such as behaviours or the presence of disease, even if not yet diagnosed,” said “This is one of the reasons why proteins are such good indicators of our current and future health state and have the potential to improve clinical prediction across different and diverse diseases.”
Dr Stephen Williams, Chief Medical Officer of SomaLogic, who led the study, said:
It’s remarkable that plasma protein patterns alone can faithfully represent such a wide variety of common and important health issues, and we think that this is just the tip of the iceberg. We have more than a hundred tests in our SomaSignal pipeline and believe that large-scale protein scanning has the potential to become a sole information source for individualised health assessments.”
While this study shows a proof-of-principle, the researchers say that as technology improves and becomes more affordable, it is feasible that a comprehensive health evaluation using a battery of protein models derived from a single blood sample could be offered as routine by health services.
Peter Ganz, MD, co-leader of this study and the Maurice Eliaser Distinguished Professor of Medicine at the UCSF and Director of the Center of Excellence in Vascular Research at Zuckerberg San Francisco General Hospital and Trauma Center, said:
“This proof of concept study demonstrates a new paradigm that measurement of blood proteins can accurately deliver health information that spans across numerous medical specialties and that should be actionable for patients and their healthcare providers. I expect that in the future we will look back at this Nature Medicine proteomic study as a critical milestone in personalising and thus improving the care of our patients.”
Go deeper with Bing News on:
Liquid health check
- Finding an alternative to Vydateon February 26, 2021 at 7:38 am
All four emergency applications for the use of Vydate (oxamyl) in 2021 potato, carrot, parsnip, garlic and onion crops have been rejected by the Health and Safety Executive.
- Are You Ready to Buy Property? Check These 4 Personal Finance Ratioson February 26, 2021 at 7:05 am
How do I know if I’m financially ready to buy a property? Use these 4 personal finance ratios to quickly assess your own financial readiness.
- How to get water out of iPhone and make it functional againon February 25, 2021 at 10:19 pm
Dropped your iPhone into water or some other liquid? Here's a detailed guide on how to get water out of iPhone and restore its functionality to normal.
- Pothole season in full swing: Why you’ll want to avoid hitting them, what to do if you can’t avoid oneon February 25, 2021 at 4:57 pm
We are still in February and already pothole season is rearing its ugly head. It’s a little earlier than normal this year, and with winter not over yet, we have a look at the problem.
- Hundreds of MPS employees receive first COVID-19 vaccineon February 25, 2021 at 3:18 pm
Hundreds of Montgomery Public Schools employees got their first COVID-19 vaccine shot at Alabama State University.
Go deeper with Google Headlines on:
Liquid health check
Go deeper with Bing News on:
- Predictive Oncology Inc. (NASDAQ: POAI) Receives 'Buy' Rating from Litchfield Hills Research in First Analyst Coverage Reporton February 27, 2021 at 5:39 am
Calling POAI undervalued, Litchfield initiates coverage of Predictive Oncology with Buy rating, $3 price target ; The drug industry is changing a ...
- Medical Coding – know all about job role which merges coding and medicineon February 26, 2021 at 11:48 pm
Medical coders have been among the most in-demand healthcare professionals. For the life sciences and other paramedical graduates, this niche work offers a lucrative career that is gaining popularity.
- How Japan Is Using The World’s Most Powerful Supercomputer To Accelerate Personalized Medicineon February 25, 2021 at 4:33 pm
In Japan, scientists are harnessing the world's most powerful supercomputer, Fugaku, to discover new customized treatments and drug therapies.
- Medisafe raises $30 million for predictive AI that reminds people to take their pillson February 25, 2021 at 12:00 pm
Medisafe, a startup developing a platform to promote medication adherence, has raised $30 million in venture capital.
- Medisafe raises $30 million for predictive AI that reminds people to take their pills – Jawebon February 25, 2021 at 4:19 am
Medisafe, a startup developing a personalized medication management platform designed to help patients stay on top of their prescriptions, today announced that it raised $30 million. The company says ...